These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28898512)

  • 41. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knowledge and Practice of Parents Towards Measles, Mumps and Rubella Vaccination.
    Hussein SZ; Mardia N; Amirah M; Hashim R; Abu Bakar SH
    Malays J Med Sci; 2022 Jun; 29(3):90-98. PubMed ID: 35846488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections.
    Sørup S; Benn CS; Poulsen A; Krause TG; Aaby P; Ravn H
    JAMA; 2014 Feb; 311(8):826-35. PubMed ID: 24570246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6-14 Months During a Measles Outbreak in The Netherlands in 2013-2014.
    van der Maas NA; Woudenberg T; Hahné SJ; de Melker HE
    J Infect Dis; 2016 May; 213(9):1466-71. PubMed ID: 26690343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MMR vaccine uptake rates: a data validation study.
    Ghebrehewet S; Falconer M; McDonald P; Schlecht B
    Commun Dis Public Health; 2003 Jun; 6(2):144-6. PubMed ID: 12889295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The web and public confidence in MMR vaccination in Italy.
    Aquino F; Donzelli G; De Franco E; Privitera G; Lopalco PL; Carducci A
    Vaccine; 2017 Aug; 35(35 Pt B):4494-4498. PubMed ID: 28736200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The contribution of single antigen measles, mumps and rubella vaccines to immunity to these infections in England and Wales.
    Sonnenberg P; Crowcroft NS; White JM; Ramsay ME
    Arch Dis Child; 2007 Sep; 92(9):786-9. PubMed ID: 17412744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interpreters' knowledge and perceptions of childhood vaccines: Effect of an educational session.
    Madlon-Kay DJ; Smith ER
    Vaccine; 2020 Jan; 38(5):1216-1219. PubMed ID: 31757578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal.
    Gonçalves G; Frade J; Nunes C; Mesquita JR; Nascimento MS
    Vaccine; 2015 Sep; 33(39):5057-63. PubMed ID: 26319061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic factors influencing childhood vaccination in two northern Italian regions.
    Anello P; Cestari L; Baldovin T; Simonato L; Frasca G; Caranci N; Grazia Pascucci M; Valent F; Canova C
    Vaccine; 2017 Aug; 35(36):4673-4680. PubMed ID: 28757057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.
    Petrovic M; Roberts R; Ramsay M
    BMJ; 2001 Jan; 322(7278):82-85. PubMed ID: 11154622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
    Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving MMR vaccination rates: herd immunity is a realistic goal.
    Cockman P; Dawson L; Mathur R; Hull S
    BMJ; 2011 Oct; 343():d5703. PubMed ID: 21971162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How practice nurses engage with parents during their consultations about the MMR vaccine: a qualitative study.
    Hill MC; Salmon D; Chudleigh J; Aitken LM
    Prim Health Care Res Dev; 2021 May; 22():e20. PubMed ID: 34039463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Immunisation Beliefs and Intentions Measure (IBIM): predicting parents' intentions to immunise preschool children.
    Tickner S; Leman PJ; Woodcock A
    Vaccine; 2010 Apr; 28(19):3350-62. PubMed ID: 20206284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tracking mothers' attitudes to MMR immunisation 1996-2006.
    Smith A; Yarwood J; Salisbury DM
    Vaccine; 2007 May; 25(20):3996-4002. PubMed ID: 17395344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measles high school vaccination program, 2014-2015: online survey of parents in NSW, Australia.
    Nicholl S; Seale H; Campbell-Lloyd S
    Public Health Res Pract; 2018 Jun; 28(2):. PubMed ID: 29925088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.